Schedule 13G ownership disclosure
OBALON THERAPEUTICS INC
Security class unavailable · CUSIP: 67424L209
Event date: 2019-08-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 365,412
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-003227
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Aug 06, 2019
- Reporting period
- Aug 02, 2019
- Description
- Schedule 13G beneficial ownership